France First EU Country To Make Truvada Available For HIV Prevention
This article was originally published in Scrip
The French regulatory agency, ANSM, is to make Gilead's combination HIV drug Truvada available for pre-exposure prophylaxis (PrEP), an unapproved indication, under a "temporary use recommendation" (RTU). The announcement was made on Dec. 1 to coincide with World AIDS Day.
Register for our free email digests: